European Journal of Gastroenterology & Hepatology

Article	Citations
Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study	56
COVID-19 and liver injury: a meta-analysis	53
COVID-19 and the liver: overview	44
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis	42
Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis	38
Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis	37
Systemic inflammation and portal vein thrombosis in cirrhotic patients with gastroesophageal varices	36
Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: a systematic review and meta-analysis	34
Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis	33
Deep learning enabled classification of Mayo endoscopic subscore in patients with ulcerative colitis	32
Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of	31
Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment	31
Accuracy of liver and spleen stiffness on magnetic resonance elastography for detecting portal hypertension: a systematic review and meta-analysis	29
Malnutrition and sarcopenia are prevalent among inflammatory bowel disease patients with clinical remission	29
Mean platelet volume and platelet to lymphocyte count ratio are associated with hepatitis B-related liver fibrosis	28
Sarcopenia as prognostic factor for survival after orthotopic liver transplantation	27
Neutrophil–lymphocyte ratio predicts early outcomes in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: a multicenter analysis	27
Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19	27
Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management	26
The dietary practices and beliefs of people living with inactive ulcerative colitis	26
Elevated platelet distribution width and red cell distribution width are associated with autoimmune liver diseases	25
Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? – A systematic review and network meta-analysis	24
Albumin–bilirubin score is associated with in-hospital mortality in critically ill patients with acute pancreatitis	23
Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis	23
Clinical feasibility of panintestinal (or panenteric) capsule endoscopy: a systematic review	21

Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease	21
Thromboelastography versus standard coagulation testing in the assessment and reversal of coagulopathy among cirrhotics: a systematic review and meta-analysis	21
Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis	20
Developing a better biopsychosocial understanding of pain in inflammatory bowel disease: a cross-sectional study	19
Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients	19
Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial	19
Needle-based confocal laser endomicroscopy in pancreatic cysts: a meta-analysis	19
Clinical course and outcome among patients with acute pancreatitis and COVID-19	18
Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical t	18
Fibrosis-4 index and mortality in coronavirus disease 2019: a meta-analysis	18
ESPGHAN ‘biopsy-sparing’ guidelines for celiac disease in children with low antitransglutaminase during COVID-19	18
The effect of malnutrition on the infectious outcomes of hospitalized patients with cirrhosis: analysis of the 2011–2017 hospital data	18
Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study	17
Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease	17
The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven	17
Single-step endoscopic ultrasound-guided multiple gateway drainage of complex walled-off necrosis with lumen apposing metal stents	17
Recurrence of spontaneous bacterial peritonitis in cirrhosis: novel predictors	17
Biliary stent migration: why, how, and what?	17
Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy	16
Micronutrient deficits in patients with chronic pancreatitis: prevalence, risk factors and pitfalls	16
Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis	16
Gastrointestinal manifestations of COVID-19: results from a European centre	16
Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease	16
High rates of serology testing for coeliac disease, and low rates of endoscopy in serologically positive children and adults in Israel: lessons from a large real-world database	15
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients	15
Clinical phenotype and mortality in patients with idiopathic small bowel villous atrophy: a dual-centre international study	15
Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study	15
Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn’s disease in patients started on antitubercular therapy	14
The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage	14
Decreased number of colonic tuft cells in quiescent ulcerative colitis patients	14
Comparative study of spironolactone and eplerenone in management of ascites in patients of cirrhosis of liver	14
Clinical characteristics and prognostic factors for Crohn’s disease relapses using natural language processing and machine learning: a pilot study	14
Sarcopenia is associated with longer hospital stay and multiorgan dysfunction in alcoholic hepatitis	14
Efficacy of sofosbuvir/velpatasvir/voxilaprevir in direct-acting antiviral experienced patients with hepatitis C virus	14
Prevalence, incidence and clinical features of SARS-CoV-2 infection in adult coeliac patients	14
Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease	13
Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice	13
Real-world clinical and endoscopic outcomes after one year tofacitinib treatment in ulcerative colitis	13
Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial	13
A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes	13
Efficacy of endoscopic triage during the Covid-19 outbreak and infective risk	13
Portal hypertension in primary biliary cholangitis: prevalence, natural history and histological correlates	13
Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial	13
Risk factors for adverse events of colorectal endoscopic submucosal dissection: a systematic review and meta-analysis	12
Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus	12
Is there any role of renin-angiotensin system inhibitors in modulating inflammatory bowel disease outcome?	12
Efficacy of albumin–bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt	12
Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots	12
A new panenteric capsule endoscopy-based strategy in patients with melena and a negative upper gastrointestinal endoscopy: a prospective feasibility study	12
Small molecule drugs in the treatment of inflammatory bowel diseases: which one, when and why? – a systematic review	12

Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study	12
Fecal and mucosal microbiota profiling in pediatric inflammatory bowel diseases	12
Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea	12
Outcomes of early versus delayed endoscopy in cirrhotic patients with acute variceal bleeding: a systematic review with meta-analysis	12
Evaluation of liver fibrosis in patients with Wilson’s disease	12
The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma	12
Hepatic veno-occlusive disease development in the hematopoietic stem cell transplantation patients: incidence and associated risk factors, a meta-analysis	12
Primary presentation of COVID-19 solely with gastrointestinal symptoms: a problem for the containment of the disease	11
microRNA in inflammatory bowel disease at a glance	11
Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease	11
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis	11
Neutrophil–lymphocyte ratio and the risk of hepatocellular carcinoma in patients with hepatitis B-caused cirrhosis	11
Paediatric inflammatory bowel disease in India: a prospective multicentre study	11
Artificial intelligence can increase the detection rate of colorectal polyps and adenomas: a systematic review and meta-analysis	11
Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis	11
Polymorphisms in Toll-like receptors 1, 2, 5, and 10 are associated with predisposition to Helicobacter pylori infection	11
The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection	10
Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn’s disease – a real-world two-center cohort study	10
Leucine-rich alpha-2 glycoprotein 1, high mobility group box 1, matrix metalloproteinase 3 and annexin A1 as biomarkers of ulcerative colitis endoscopic and histological activity	10
Evaluation of the efficacy and safety of direct oral anticoagulants in the treatment of portal vein thrombosis	10
Impact of pretransplant frailty and sarcopenia on the post-transplant prognosis of patients with liver cirrhosis: a systematic review	10
Oral manifestations of inflammatory bowel disease: the neglected piece of the puzzle	10
Challenging diagnosis of gastrointestinal tuberculosis made simpler with multi-targeted loop-mediated isothermal amplification assay	10
Association between aspartate aminotransferase-to-alanine aminotransferase ratio and insulin resistance among US adults	10
Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update	10
COVID-19: gastrointestinal symptoms from the view of gut–lung axis	10
Endoscopic submucosal dissection of gastric neoplastic lesions in Western countries: systematic review and meta-analysis	10
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort	10
A systematic review and meta-analysis of disease severity and risk of recurrence in young versus elderly patients with left-sided acute diverticulitis	10
Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis	10
Gastroesophageal Reflux Disease – Health-Related Quality of Life Questionnaire: prospective development and validation in Italian	10
Proactive therapeutic drug monitoring is more effective than conventional management in inducing fecal calprotectin remission in inflammatory bowel disease	10
Feasibility and learning curve of unsupervised colorectal endoscopic submucosal hydrodissection at a Western Center	10
Dual biologic therapy with Vedolizumab and Ustekinumab for refractory Crohn’s disease in children	10
Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: A retrospective study	10
The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities	10
Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease	10
Kinetic patterns of liver enzyme elevation with COVID-19 in the USA	10
Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt	10
Case series and review of liver dysfunction in COVID-19 patients	10
Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label	9
Computer-aided detection of colorectal polyps using a newly generated deep convolutional neural network: from development to first clinical experience	9
Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis	9
Gastroenterologists’ preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey	9
The current role of dual therapy for treatment of Helicobacter pylori: back to the future?	9
Endoscopic full thickness resection in the colo-rectum: outcomes from the UK Registry	9
Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase	9
Comparison of the impact of tenofovir alafenamide and entecavir on declines of hepatitis B surface antigen levels	9
Peroral endoscopic myotomy versus pneumatic dilation for achalasia: a systematic review and meta-analysis	9
Concomitant decrease of double-positive lymphocyte population CD4CD8αα and Faecalibacterium prausnitzii in patients with colorectal cancer	9
Effectiveness and safety of endoscopic treatment for duodenal variceal bleeding: a systematic review	9
Obstructive sleep apnea and severity of nonalcoholic fatty liver disease	9
The correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with nonalcoholic fatty liver disease: a cross-sectional study	9
Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients: a prospective multicentre cohort study	9
Submucosal tunnelling techniques for Zenker’s diverticulum: a systematic review of early outcomes with pooled analysis	9
Comparing endoscopic interventions to improve serrated adenoma detection rates during colonoscopy: a systematic review and network meta-analysis of randomized controlled trials	9
Incidence of spontaneous bacterial peritonitis among asymptomatic cirrhosis patients undergoing outpatient paracentesis: a systematic review and meta-analysis	9
Does gallbladder wall thickness measurement predict esophageal varices in cirrhotic patients with portal hypertension?	9
PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks	9
Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients	9
Differences in amino acid and lipid metabolism distinguish Crohn’s from idiopathic/cryptoglandular perianal fistulas by tissue metabonomic profiling and may offer clues to underlying pathogenesis	9
Frailty is strongly associated with self-reported symptom burden among patients with cirrhosis	9
Risk factors for endoscopic severity of diverticular disease of the colon and its outcome: a real-life case-control study	9
Narrow band imaging characteristics of gastric polypoid lesions: a single-center prospective pilot study	9
Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease	9
Epigenetic-sensitive challenges of cardiohepatic interactions: clinical and therapeutic implications in heart failure patients	9
Consensus document on the management preferences of patients with ulcerative colitis: points to consider and recommendations	8
Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience	8
The association between Dietary Diversity Score and odds of nonalcoholic fatty liver disease: a case-control study	8
Continuous insulin therapy versus apheresis in patients with hypertriglyceridemia-associated pancreatitis	8
Environmental exposures and the risk of inflammatory bowel disease: a case-control study from Saudi Arabia	8
Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis	8
Combining immune checkpoint inhibitor with lenvatinib prolongs survival than lenvatinib alone in sorafenib-experienced hepatocellular carcinoma patients	8
The indicative role of markers for liver injury on the severity and prognosis of coronavirus disease 2019 patients	8
Platelet–lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: an inverse probability weighting analysis	8
Association between high-density lipoprotein cholesterol and apolipoprotein A-I and severe acute pancreatitis: a case-control study	8
Controversial risk factors for cholangiocarcinoma	8
The predictive value of procalcitonin combined with C-reactive protein and D dimer in moderately severe and severe acute pancreatitis	8
The prevalence of symptomatic uncomplicated diverticular disease could be lower than expected: a single-center colonoscopy-based cohort study	8
Natural history and predictors associated with the evolution of portal venous system thrombosis in liver cirrhosis	8

Impact of social determinants of health on colorectal cancer screening and surveillance in the COVID reopening phase	8
Mesalazine-induced acute pancreatitis: a rare adverse reaction but with important therapeutic implications in ulcerative colitis	8
Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn’s disease	8
Hepatitis A hospitalizations among kidney transplant recipients in the United States: nationwide inpatient sample 2005–2014	8
Upregulation of microRNA-219-5p relieves ulcerative colitis through balancing the differentiation of Treg/Th17 cells	8
Systematic review and meta-analysis: risks of postoperative complications with preoperative use of anti-tumor necrosis factor-alpha biologics in inflammatory bowel disease patients	8
Liver cirrhosis affects serum lactate level measurement while assessing disease severity in patients with sepsis	8
Landmarks for dual biological therapy in inflammatory bowel disease: lesson from two case reports of vedolizumab in combination with ustekinumab	8
Symptoms and demographic factors associated with early-onset colorectal neoplasia among individuals undergoing diagnostic colonoscopy	8
The effect of a nurse-led advice line and virtual clinic on inflammatory bowel disease service delivery: an Australian study	8
Eosinophilic esophagitis: is the Th2 inflammation protective against the severe form of COVID-19?	8
Serum transglutaminase antibodies do not always detect the persistent villous atrophy in patients with celiac disease on a gluten-free diet	8
Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: compari	8
The prognostic impact of different stages of acute kidney injury in patients with decompensated cirrhosis: a prospective cohort study	7
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease	7
The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission	7
Safety and effectiveness of ustekinumab in elderly Crohn’s disease patients	7
African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians	7
Acoustic radiation force impulse imaging of pancreas in patients with early onset idiopathic recurrent acute pancreatitis	7
Obesity and myosteatosis: the two characteristics of dynapenia in patients with cirrhosis	7
Predictors of survival in portopulmonary hypertension: a 20-year experience	7
The impact of acute kidney injury on mortality and clinical outcomes in patients with alcoholic cirrhosis in the USA	7
Low prevalence of upper endoscopic gastrointestinal findings despite high frequency of alarm symptoms at the time of diagnosis in adult coeliac disease	7
Extrapancreatic infections are common in acute pancreatitis and they are related to organ failure: a population-based study	7
Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study	7
Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients	7
Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece	7
Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study	7
Role of noninvasive tools for prediction of clinically evident portal hypertension in children	7
Association between effective hepatic blood flow and the severity and prognosis of hepatitis B virus-related acute on chronic liver failure	7
Exploring and predicting mortality among patients with end-stage liver disease without cancer: a machine learning approach	7
Increased prevalence of irritable bowel syndrome in migraine patients: a systematic review and meta-analysis	7
The diagnostic accuracy of ascitic calprotectin for the early diagnosis of spontaneous bacterial peritonitis: systematic review and meta-analysis	7
Reticuloendothelial activation correlates with disease severity and predicts mortality in severe alcoholic hepatitis	7
Incidence and predisposing factors for de novo post-COVID-19 irritable bowel syndrome	7
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD	7
The prevention and management of Crohn’s disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey	7
MRI-determined liver fat correlates with risk of metabolic syndrome in patients with nonalcoholic fatty liver disease	7
Serum matrix metalloproteinase-9 concentration as a marker of disease activity in patients with inflammatory bowel disease	7
Muscle deficits with normal bone microarchitecture and geometry in young adults with well-controlled childhood-onset Crohn’s disease	7
Optical effect of spraying l-menthol on gastric intestinal metaplasia visualized by linked color imaging	7
Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy	7
Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn’s disease: real-life cohort from a tertiary referral center	7
Safety and efficacy of switching from infliximab biosimilar CT-P13 to infliximab biosimilar SB2 in patients with inflammatory bowel disease	7
Standardized approach of albumin, midodrine and octreotide on hepatorenal syndrome treatment response rate	6
Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a systematic review and meta-analysis	6
Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis	6
Gastrointestinal manifestations of angioedema: a potential area of misdiagnosis	6
Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure related bleeding in cirrhosis	6
IL-10-1082G>A polymorphism, use of opioids and age affect the course of acute pancreatitis	6
Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience	6
Protein misfolding in combination with other risk factors in CEL-HYB1-mediated chronic pancreatitis	6
Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R)	6
Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection	6
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn’s disease	6
Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations	6
COVID-19: an emergent cause of liver injury?	6
De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors	6
Association of portal venous system thrombosis with endoscopic variceal treatment: a systematic review and meta-analysis	6
Alcohol consumption increases the incidence of hepatocellular carcinoma in patients with hepatitis B cirrhosis but not in patients with hepatitis C cirrhosis	6
Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality	6
Fibrosis improvement in patients with HCV treated with direct-acting antivirals	6
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment	6
External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population	6
Metal versus plastic stents in the management of benign biliary strictures: systematic review and meta-analysis of randomized controlled trials	6
Exploration of interventional therapy strategy for portal vein occlusion: a case series study	6
Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease	6
Incidences of hypothyroidism and autoimmune thyroiditis are increased in patients with nonalcoholic fatty liver disease	6
Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis	6
Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d-penicillamine	6
Association between sleep disturbance and multidimensional frailty assessed by Frailty Index in hospitalized cirrhosis	6
SPP1 in infliximab resistant ulcerative colitis and associated colorectal cancer: an analysis of differentially expressed genes	6
Management of gastrointestinal bleeding during COVID-19: less is more!	6
Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis	6
Epidemiological approximation of the enteric manifestation and possible fecal–oral transmission in COVID-19: a preliminary systematic review	6
The Malnutrition Universal Screening Tool can predict malnutrition in patients with esophageal achalasia	6
Very low rate of residual neoplasia after non-curative endoscopic submucosal dissection: a western single-center experience	6
Seroprevalence of hepatitis E virus in Argentinean blood donors	6
Study of serology and genetics of celiac disease in patients with juvenile systemic lupus erythematosus ‘celiac in juvenile systemic lupus’	5
The correlations between hepatitis B virus infection and hepatocellular carcinoma with portal vein tumor thrombus or extrahepatic metastasis	5
Relationship between atrophic gastritis, serum ghrelin and body mass index	5
Interrater reliability of the assessment of disease activity by gastrointestinal ultrasound in a prospective cohort of patients with inflammatory bowel disease	5
Inflammatory bowel disease versus Chlamydia trachomatis infection: a case report and revision of the literature	5
Insulin-like growth factor 2 binding protein 3 expression on endoscopic ultrasound guided fine needle aspiration specimens in pancreatic ductal adenocarcinoma	5
Structural validation and dyadic child–parent measurement invariance of the celiac disease quality of life questionnaire	5
Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt	5
Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn’s disease	5
Risk of liver fibrosis progression in patients with suboptimal diagnosis of hepatitis C virus infection	5
Intestinal failure in Finland: prevalence and characteristics of an adult patient population	5
Macro- and micronutrients in metabolic (dysfunction) associated fatty liver disease: association between advanced fibrosis and high dietary intake of cholesterol/saturated fatty acids	5
Self-reported nonceliac wheat sensitivity in an outpatient digestive endoscopy center: high frequency but insufficient medical approach	5
The potential value of miRNA-223 as a diagnostic biomarker for Egyptian colorectal patients	5
Protocol liver biopsies in stable long-term pediatric liver transplant recipients: risk or benefit?	5
Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD	5
Liver cirrhosis prediction for patients with Wilson disease based on machine learning: a case–control study from southwest China	5